Analyzing Agilent Technologies (A) and Boston Scientific (BSX)
Agilent Technologies (NYSE: A) and Boston Scientific (NYSE:BSX) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership.
Agilent Technologies pays an annual dividend of $0.53 per share and has a dividend yield of 0.8%. Boston Scientific does not pay a dividend. Agilent Technologies pays out 25.2% of its earnings in the form of a dividend.
This is a breakdown of recent ratings and price targets for Agilent Technologies and Boston Scientific, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Agilent Technologies currently has a consensus price target of $69.23, suggesting a potential upside of 3.77%. Boston Scientific has a consensus price target of $30.83, suggesting a potential upside of 23.14%. Given Boston Scientific’s stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than Agilent Technologies.
Volatility and Risk
Agilent Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
Valuation and Earnings
This table compares Agilent Technologies and Boston Scientific’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Agilent Technologies||$4.47 billion||4.80||$684.00 million||$2.10||31.77|
|Boston Scientific||$8.39 billion||4.10||$347.00 million||$0.61||41.05|
Agilent Technologies has higher earnings, but lower revenue than Boston Scientific. Agilent Technologies is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.
This table compares Agilent Technologies and Boston Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider & Institutional Ownership
90.6% of Boston Scientific shares are held by institutional investors. 0.7% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Agilent Technologies Company Profile
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Boston Scientific Company Profile
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.